317 M
Pill imprint 317 M has been identified as Cimetidine 300 mg.
Cimetidine is used in the treatment of gerd; stomach ulcer; human papilloma virus; obesity; lung cancer (and more), and belongs to the drug class H2 antagonists. There is no proven risk in humans during pregnancy.
Cimetidine 300 mg is not subject to the Controlled Substances Act.
See also related documents.
Cimetidine Images
- Imprint:
-
317
M - Strength:
- 300 mg
- Color:
- Green
- Size:
- 10.00 mm
- Shape:
- Five-sided
- Availability:
- Rx and/or OTC
- Inactive Ingredients:
- croscarmellose sodium
crospovidone
hypromellose
lecithin
magnesium stearate
microcrystalline cellulose
polydextrose
polyethylene glycol
povidone
pregelatinized starch
sodium alginate
sodium lauryl sulfate
titanium dioxide
triacetin
vanillin
FD&C Blue No. 1 Aluminium Lake
FD&C Yellow No. 6 Aluminum Lake
FD&C Yellow No. 10 Aluminum Lake
- Drug Class:
- H2 antagonists
- Pregnancy Category:
- B - No proven risk in humans
- CSA Schedule:
- N - Not a controlled drug
- Manufacturer:
- Mylan Pharmaceuticals Inc.
- National Drug Code (NDC):
- 00378-0317
| NDC Code | Manufacturer / Repackager |
|---|---|
| 54569-3837 | A S Medication Solutions LLC (repackager) |
| 66267-0056 | Nucare Pharmaceuticals Inc (repackager) |
| 16590-0048 | Stat RX USA LLC (repackager) |
Note: Inactive ingredients may vary.
More Cimetidine resources
- Cimetidine (Wolters Kluwer)
- Cimetidine Solution (Wolters Kluwer)
- Cimetidine Suspension (Wolters Kluwer)
- cimetidine (Cerner Multum)
- Cimetidine (AHFS DI)
- Cimetidine Hydrochloride (AHFS DI)
- Cimetidine (FDA)
- Cimetidine Injection (FDA)
- Cimetidine Sodium Chloride (FDA)
- Cimetidine Tablets (FDA)
- Leader Heartburn Relief (FDA)
- Sunmark Heartburn Relief Drug Facts (FDA)
- Tagamet HB Drug Facts (FDA)
- Cimetidine (Wolters Kluwer)


